Background Although previous studies have found that maternal smoking decreases the risk of pregnancy-induced hypertension (PIH), the difference of this effect between primiparous and multiparous women has not been well studied and the results of the exposure-response relationships between maternal smoking and PIH are inconsistent. No previous study has specifically examined the relationship between maternal smoking and eclampsia.
conducted here is needed in order to evaluate results for primiparous and multiparous women separately with adequate statistical power. Consistent exposure-response relationships between maternal smoking and PIH and pre-eclampsia are also lacking. 6, 8, 12, [15] [16] [17] Other issues also need to be addressed. Most previous studies did not adjust for important confounding factors in the relationship between smoking and pre-eclampsia, such as socioeconomic status, 18, 19 and weight gain during pregnancy. 19 No studies have specifically examined the relationship between maternal smoking and eclampsia, probably owing to the small number of cases available for analysis. The present analysis is based on data from a large populationbased study in the US. Our specific objective is to examine associations between maternal smoking and PIH and eclampsia in both primiparous and multiparous women and to determine whether smoking may affect PIH and eclampsia in a dose-dependent manner.
Methods
The data were derived from the 1998 US national linked birth/ infant mortality database provided by the National Center for Health Statistics, Centers for Disease Control and Prevention. 20 Information on live births, fetal deaths, and infant deaths up to 1 year was recorded in the 50 states and the District of Columbia, pre-coded according to uniform specifications, and subjected to vigorous quality checks by the National Center for Health Statistics. 21 Women with multiple births, gestational age ,20 weeks, cardiac disease, diabetes, chronic hypertension, renal disease, or no information on maternal smoking, were excluded from our analyses. This database included sociodemographic information on the parents, maternal lifestyle factors such as smoking and alcohol consumption during pregnancy, obstetric history, complications associated with pregnancy, maternal weight gain during pregnancy, type of delivery, birth weight, and gestational age at delivery. Subjects were classified into nonsmokers and smokers, with a smoker defined as a person who smoked at any time during pregnancy. The daily average smoking consumption was also recorded in one of four categories (1-5, 6-10, 11-20 , and .20 cigarettes per day). The sociodemographic information was collected from the mother or the medical records at the time of delivery when the birth certificate was completed.
PIH and eclampsia were pre-coded in this database. PIH was referred to as an increase in blood pressure of at least 30 mm Hg systolic or 15 mm Hg diastolic on two measurements taken 6 h apart after the 20th week of gestation compared with previous assessment by professionals. Cases of chronic hypertension, defined as blood pressure persistently .140/90, diagnosed prior to onset of pregnancy or before the 20th week of gestation, were excluded from this diagnosis. Pre-eclampsia was defined as PIH with proteinuria of at least 11 or more on dipstick in two samples 6 h apart or .0.3 g in a 24 h urine collection. Eclampsia was referred to as the occurrence of convulsions and/or coma, unrelated to other conditions in women with signs and symptoms of pre-eclampsia.
We tabulated the important characteristics of the study population and calculated the incidence of PIH and eclampsia according to these characteristics. Crude and adjusted odds ratios (ORs) for maternal smoking associated with PIH and eclampsia were estimated using unconditional logistic regression. Potential confounding variables included in the regression models were maternal age, race, education, marital status, parity, alcohol drinking during pregnancy, adequacy of pre-natal care, weight gain during pregnancy, and gestational age. The modified Kessner index was applied to measure the adequacy of prenatal care which was pre-coded by the National Center for Health Statistics according to first trimester initiation of care and specified number of pre-natal care visits for the gestational age at delivery. 22 The analysis was further stratified by parity.
Exposure-response relationships were assessed by testing for linear trend. All analyses were performed using SAS-PC statistical software version 8 (SAS Inc., NC).
Results
The data were derived from the national linked birth/infant mortality database for 1998. A total of 109 799 women with PIH were also excluded in the analysis of eclampsia. After these exclusions, 2 619 513 pregnancies were available for the analysis of PIH, along with 2 524 031 pregnancies for the analysis of eclampsia (some subjects had more than one exclusion condition).
Maternal and fetal characteristics of the study subjects are shown in Table 1 , along with the incidence of PIH and eclampsia (Table 1) . About 12.7% of mothers smoked during pregnancy. The incidences of PIH and eclampsia were 3.7 and 0.3%, respectively. The incidence of both PIH and eclampsia was higher in non-smokers, teenage mothers, women >40 years of age, mothers whose gestational weight gain .45 pounds, and mothers who delivered their babies before 36 weeks. Multiparous women, mothers whose race was other than white and black, women whose weight gain was ,35 pounds, and those who delivered their babies .40 weeks were less likely to develop PIH and eclampsia.
The risks of PIH and eclampsia in relation to maternal smoking are shown in Tables 2 and 3 Table 4 describes the exposure-response relationships between maternal smoking and both PIH and eclampsia. Although a significant inverse exposure-response relationship between maternal smoking and eclampsia was observed, the risk of PIH did not appear to depend strongly on the amount smoked. 
Discussion
The present large-scale population-based study provides evidence that maternal cigarette smoking is associated with a decreased risk of developing PIH and eclampsia in both primiparous and multiparous women. There was a significant inverse exposure-response relationship between maternal smoking and eclampsia. In a previous systematic review of available data from studies conducted in different countries, an odds ratio of 0.7 for PIH for current vs never smokers was reported, 23 a value similar to the adjusted ORs of 0.80 for PIH and 0.75 for eclampsia in the present study. Our study, which involves a much larger sample size than previous studies by Marten et al. 10 and Xiong et al. 9 indicated that the effects of maternal smoking on PIH and eclampsia were similar in primiparous and multiparous women. Several papers have reported that maternal smoking may have relatively little impact on pre-eclampsia in multiparous women. 1, 9, 24, 25 However, the lack of an association in multiparous women may be due to inadequate sample size, since the incidence of preeclampsia is low in multiparous women. 9 Our findings are consistent with those reported by Conde-Agudelo and Belizan 26 in which the pattern of risk factors among primiparous and multiparous women were quite similar. In our study, eclampsia, but not PIH, demonstrated an inverse exposure-response relationship. Ansari et al. 27 also found that the association of eclampsia with tobacco smoking was inverse and dose related when they conducted a case-control study to examine the risk of eclampsia in relation to several maternal characteristics and exposure. Their results were very comparable with ours. Potential biological mechanisms underlying observed association between maternal smoking and PIH/pre-eclampsia/ eclampsia are not fully understood. Pre-eclampsia has been linked initially to the immune system. 21 Women who smoke may have an underlying decreased immune response and, therefore, may be less likely to develop the exaggerated immune response seen in pre-eclampsia. 28 Pre-eclampsia is a hypocalciuric state. 29 Smoking, which alters parathyroid hormone levels 30 and adrenal cortex steroid production, 31,32 might contribute to an altered calcium metabolism. Zhang et al. 8 speculated that smoking might induce some liver enzymes that could metabolize any endothelial toxins produced by the placenta because past smoking appeared to continue its protective effect during pregnancy. However, the incidence of phenobarbital (a well-known inductor of liver enzyme bioactivity) among women with hypertension was similar to that in the rest of the population. Since smokers are exposed to numerous chemicals present in cigarette smoke, it is important to determine the compound(s) that are involved in reducing the risk of developing PIH/pre-eclampsia/eclampsia. Thiocyamite may have a hypotensive effect. 33 Nicotine may inhibit the production of thromboxane A 2 , a vascoconstrictor and a platelet aggregation stimulator. 34 However, a recent study on the use of snuff (a non-combustible form of tobacco) in pregnancy demonstrated no effect on the incidence of pre-eclampsia, suggesting that the factors associated with a decreased incidence of pre-eclampsia in cigarette smokers may be combustible Ã OR and 95% CI with adjustment for maternal age, race, education, marital status, maternal drinking, maternal weight gain during pregnancy, adequacy of pre-natal care, and gestational age. Ã OR and 95% CI with adjustment for maternal age, race, education, marital status, maternal drinking, maternal weight gain during pregnancy, adequacy of pre-natal care, and gestational age. which is consistent with previous suggestions that placental oxidative stress may be involved in the aetiology of preeclampsia. 2 The mechanism may be mediated by the effect of maternal smoking on endogenous oestrogen levels. Maternal smoking during pregnancy has been reported to lower oestrogen levels by 20%. 37, 38 Plasma oestrogen levels are lower in preeclamptic patients than in the normal pregnancies 39, 40 and using estradiol benzoate and progesterone for the treatment of severe pre-eclampsia has obtained good results. 41 However, these studies were based on small number of patients and the possibility of type I error could not be excluded. Our study has several strengths in comparison with previous studies in this area. It is the largest population-based study conducted to date that allowed us insight into the relationship between maternal smoking and eclampsia. PIH and eclampsia were coded according to uniform specifications. The data contain detailed information on average daily cigarette consumption during pregnancy as well as maternal demographic and medical information.
The limitations of using the birth certificate data must be acknowledged. As cigarette use during pregnancy was selfreported, underreporting is likely. 42 In this case, the true magnitude of the effect of maternal smoking on PIH and eclampsia may have been underestimated. There was no information on paternal smoking or second-hand smoke, which might confound the relationship between maternal smoking and PIH, although Parazzini et al. 11 did not find a relationship between paternal smoking and the risk of PIH. In addition, there was no information on pre-pregnancy smoking or smoking cessation during pregnancy. Occasional smokers were included in non-smokers in this database, which might attenuate our effect estimates. Another concern is related to possible misclassification of pregnancy outcomes. As eclampsia is a severe and acute disease, the misclassification of eclampsia might be very low. However, the incidence of PIH in the database appears to be lower than in previous studies. 1 If the probabilities of misclassification of each variable are the same for each category of the other variable (non-differential misclassification) and if the errors for different variables are independent, the estimated effect is usually biased toward the null value. 43 There is no reason to believe that the misclassification of PIH and eclampsia is related to (or dependent on) smoking status. Therefore, the effect of smoking would be stronger if there is no misclassification of PIH and eclampsia. Unfortunately, we could not examine the smoking effect on pre-eclampsia from PIH additionally because only PIH and eclampsia were coded in our database. Despite the apparent 'protective' effect of smoking on the risk of PIH and eclampsia, smoking is associated with substantial increases in neonatal mortality and morbidity. Smokers with preeclampsia demonstrated very high risks of perinatal mortality, abrupto placentae, and small-for-age infants. 6 Perinatal outcomes were significantly less favourable among pre-eclamptics who smoked. 44 Consequently, pregnant women should be strongly encouraged to quit smoking. Nonetheless, a better understanding of the mechanisms by which smoking may affect the pathogenesis of hypertension during pregnancy may provide clues to preventive and therapeutic measures that may be taken in the future.
